Day One Biopharmaceuticals

Day One Biopharmaceuticals

Day One Biopharmaceuticals

We are a new biotech company focused on developing new cancer therapies for patients of all ages.
Raised
$60M
Follow us
Alexa global traffic share
Latest funding
$60,000,000
Venture capital (Series A) - 2020
Canaan Partners Atlas Venture Access Biotechnology
Team Size
1–10
Employees
$60,000,000 Venture capital (Series A)
WSJ Venture Capital , FinSMEs

Cancer Drugmaker Day One Biopharmaceuticals Launches With $60 Million